|
Press Releases |
|
|
|
Friday, November 15, 2019 |
|
Global BioLife to Present 3F Antimicrobial Fragrance at 2020 ASM Biothreats |
Global BioLife Inc, the U.S.subsidiary of SGX-listed Singapore eDevelopment Ltd (SeD), will present research on its 3F Antimicrobial Fragrance as a new method to prevent and treat Tuberculosis at the 2020 ASM Biothreats conference, taking place from 28 to 30 January 2020 in Arlington, Virginia. more info >> |
|
Tuesday, October 29, 2019 |
|
Global BioLife to present Functional Fragrance Formula at the American Society for Microbiology's Biothreats Conference as a New Method to Prevent and Treat Tuberculosis |
SGX-listed Singapore eDevelopment Limited ("SeD", SGX:40V) wishes to announce that its biomedical subsidiary incorporated in Nevada, Global BioLife Inc. ("Global BioLife") will be presenting its research on its Functional Fragrance Formula ("3F") against tuberculosis at the 2020 American Society for Microbiology ("ASM") Biothreats Conference. more info >> |
|
Wednesday, July 24, 2019 |
|
Global BioLife unveils naturally modified Laetose at Harvard Global Catalyst Health Summit |
SGX-listed Singapore eDevelopment Ltd (SeD) is pleased to announce the results of clinical trials conducted on Laetose(TM), developed by its U.S. biomedical subsidiary, Global BioLife Inc. ("Global BioLife"). more info >> |
|
Wednesday, June 12, 2019 |
|
Global BioLife's 3F Mosquito Repellent Formula performs well in Independent Testing |
SGX-listed Singapore eDevelopment Ltd (SeD) wishes to announce that its U.S. biomedical subsidiary Global BioLife Inc. has independently tested its new 3F Mosquito Formula which performs well against mosquitoes for six (6) to eight (8) hours. more info >> |
|
Monday, January 28, 2019 |
|
Global BioLife's 3F Antimicrobial Fragrance shows Efficacy against Tuberculosis |
SGX-listed Singapore eDevelopment Ltd (SeD) is pleased to announce that its U.S. biomedical subsidiary Global BioLife Inc. has developed 3F Antimicrobial Fragrance, which shows efficacy against tuberculosis. more info >> |
|
Wednesday, November 7, 2018 |
|
Singapore eDevelopment's Global BioLife to present Parkinson's Research at Neuroscience 2018 |
Singapore eDevelopment (SGX: 40V) ("SeD") subsidiary, Global BioLife Inc. is pleased to announce that research of their promising drug platform, Linebacker, will be presented at Neuroscience 2018, the Annual Meeting for the International Society for Neuroscience (SfN) in San Diego, California. more info >> |
|
Monday, June 18, 2018 |
|
Singapore eDevelopment Limited Announces Corporate and Business Update |
The Board of Directors of Singapore eDevelopment Limited wishes to provide shareholders an update on the Group's operations. more info >> |
|
Thursday, May 31, 2018 |
|
Singapore eDevelopment's Global BioLife develops Low Glycemic Modified Sugar |
Singapore Exchange-listed Singapore eDevelopment Limited ("SeD") announced today that its U.S. biomedical subsidiary, Global BioLife, Inc. ("Global BioLife"), has developed a low glycemic index, naturally modified sugar - Laetose - which has the potential to affect the world's sugar market. more info >> |
|
Thursday, March 1, 2018 |
|
Singapore eDevelopment's Global BioLife confirms LB2 efficacy against Ebola |
Singapore eDevelopment (SGX: 40V; SeD) is pleased to announce biomedical subsidiary Global BioLife, Inc. has completed the initial Zaire Ebola research portion for the study of new anti-viral drug LB2, part of its new universal therapeutic drug platform, Linebacker. more info >> |
|
Wednesday, November 1, 2017 |
|
Singapore eDevelopment's Global BioLife confirms 100% Repellency of 3F Mosquito Fragrance |
SGX-listed Singapore eDevelopment Ltd (SeD) announced today that its U.S. biomedical subsidiary, Global BioLife Inc. has completed development and testing of mosquito deterring technologies including fragrances, paints, and fabric. more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
Datacloud APAC: Charting the Course for APAC's Cloud Future
May 8, 2024 16:20 HKT/SGT
|
|
|
アフリカがついに日本のビジネスにおける国境を開放
May 8, 2024 15:00: JST
|
|
|
以数智化殡葬直面变化与挑战 福寿园国际集团组团参加2024AFE亚洲殡仪及墓园博览暨会议
May 8, 2024 14:05 HKT/SGT
|
|
|
以數智化殯葬直面變化與挑戰 福壽園國際集團組團參加2024AFE亞洲殯儀及墓園博覽暨會議
May 8, 2024 14:01 HKT/SGT
|
|
|
Mitsubishi Heavy Industries Increases Dividends on Back of Historically High FY2023 Results, Releases FY2024 Guidance
May 8, 2024 14:27 JST
|
|
|
Capital.com 的客戶交易量在2023年超過了1萬億美元
May 8, 2024 12:18 HKT/SGT
|
|
|
Capital.com的客户交易量在2023年超过了1万亿美元
May 8, 2024 12:12 HKT/SGT
|
|
|
Capital.com's Client Trading Volumes Surpass USD1 trillion in 2023
May 8, 2024 12:00 HKT/SGT
|
|
|
Spritzer EcoPark Taiping Brightens up the Sky with an Enchanting Aurora Light Show at Food, Arts and Music Carnival
May 8, 2024 11:32 HKT/SGT
|
|
|
Rome becomes the first European city to offer open loop transit payments to JCB Cardmembers
May 8, 2024 12:00 JST
|
|
|
点燃新质生产力“火花” 诺奖得主英雄论道中新广州知识城
May 8, 2024 10:50 HKT/SGT
|
|
|
點燃新質生產力“火花” 諾獎得主英雄論道中新廣州知識城
May 8, 2024 10:41 HKT/SGT
|
|
|
Zhang Zhehan's Directorial Debut Documentary 'August' Premiered Online, Receiving Rave Reviews From Audiences
May 8, 2024 10:00: JST
|
|
|
Avance Clinical Expands Further into APAC with New Clinical Operations in South Korea
May 8, 2024 10:00: JST
|
|
|
NEC X Invests in Public Safety Startup Multitude Insights, Scaling AI-Powered Collaboration and Information Sharing for Law Enforcement
May 8, 2024 10:24 JST
|
|
|
|
More News >> |
|
|
|
|
|